🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- N51517105
- Market Cap
- Small Cap · $107 Million
- IPO
- 4/22/2022 · $15.00/share
Business: LAVA Therapeutics NV is an immuno-oncology company utilizing its proprietary Gammabody™ platform to develop a portfolio of bispecific gamma delta T cell engagers (bsTCEs) for the potential treatment of solid tumors and hematological malignancies.
Company Contact
- CEO
- Steve Hurly
- CFO
- Edward F. Smith
- Investor Relations
- Catherine Day, New Day Bioconsulting · 917-763-2709 · catherine@newdaybioconsulting.com